Nisa-Investment-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
3,106
Total Value
19996474845
Accession Number
0000937615-25-000003
Form Type
13F-HR
Manager Name
Nisa-Investment-Advisors
Data Enrichment
97% identified
3,019 identified87 unidentified

Holdings

3,106 positions • $20.0B total value
Manager:
Search and click to pin securities to the top
Page 140 of 150
BlueLinx Holdings Inc.
Shares:7
Value:$525
% of Portfolio:0.0% ($525/$20.0B)
i-80 Gold Corp.
Shares:897
Value:$522
% of Portfolio:0.0% ($522/$20.0B)
ALERUS FINANCIAL CORP
Shares:28
Value:$522
% of Portfolio:0.0% ($522/$20.0B)
Alto Neuroscience, Inc.
Shares:241
Value:$521
% of Portfolio:0.0% ($521/$20.0B)
Zentalis Pharmaceuticals, Inc.
Shares:327
Value:$520
% of Portfolio:0.0% ($520/$20.0B)
Getty Images Holdings, Inc.
Shares:300
Value:$519
% of Portfolio:0.0% ($519/$20.0B)
NewtekOne, Inc.
Shares:43
Value:$514
% of Portfolio:0.0% ($514/$20.0B)
T1 Energy Inc.
Shares:403
Value:$508
% of Portfolio:0.0% ($508/$20.0B)
TWIN DISC INC
Shares:67
Value:$507
% of Portfolio:0.0% ($507/$20.0B)
Clear Channel Outdoor Holdings, Inc.
Shares:454
Value:$504
% of Portfolio:0.0% ($504/$20.0B)
BEL FUSE INC /NJ
Shares:7
Value:$504
% of Portfolio:0.0% ($504/$20.0B)
Preferred Bank
Shares:6
Value:$502
% of Portfolio:0.0% ($502/$20.0B)
Kyverna Therapeutics, Inc.
Shares:259
Value:$500
% of Portfolio:0.0% ($500/$20.0B)
ArriVent BioPharma, Inc.
Shares:27
Value:$499
% of Portfolio:0.0% ($499/$20.0B)
Outlook Therapeutics, Inc.
Shares:405
Value:$494
% of Portfolio:0.0% ($494/$20.0B)
SOUTHERN FIRST BANCSHARES INC
Shares:15
Value:$494
% of Portfolio:0.0% ($494/$20.0B)
MID PENN BANCORP INC
Shares:19
Value:$492
% of Portfolio:0.0% ($492/$20.0B)
Artiva Biotherapeutics, Inc.
Shares:164
Value:$492
% of Portfolio:0.0% ($492/$20.0B)
Simulations Plus, Inc.
Shares:20
Value:$490
% of Portfolio:0.0% ($490/$20.0B)
ON24 INC.
Shares:94
Value:$489
% of Portfolio:0.0% ($489/$20.0B)